B K Link Selected Research

Drug Therapy (Chemotherapy)

11/2005	Long-term update of a phase II study of rituximab in combination with CHOP chemotherapy in patients with previously untreated, aggressive non-Hodgkin's lymphoma.
1/2001	Phase II study of rituximab in combination with chop chemotherapy in patients with previously untreated, aggressive non-Hodgkin's lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

B K Link Research Topics

Disease

3	Lymphoma (Lymphomas) 01/2017 - 01/2001
3	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2017 - 12/2001
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 11/2005 - 09/2000
2	Breast Neoplasms (Breast Cancer) 09/2001 - 02/2001
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2018
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2017
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2017
1	Hodgkin Disease (Hodgkin's Disease) 10/2008
1	Disease Progression 11/2005
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2005
1	Chromosome Aberrations (Chromosome Abnormalities) 05/2005
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 11/2004
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2001
1	Fever (Fevers) 01/2001
1	Chills 01/2001
1	Neoplasms (Cancer) 01/2001
1	Hyperplasia 01/2001

Drug/Important Bio-Agent (IBA)

3	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2005 - 01/2001
3	Rituximab (Mabthera)FDA Link 11/2005 - 09/2000
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2005 - 01/2001
2	Vitamin D FDA LinkGeneric 01/2017 - 01/2017
2	Vincristine (Oncovin)FDA LinkGeneric 11/2005 - 01/2001
2	Prednisone (Sone)FDA LinkGeneric 11/2005 - 01/2001
2	Monoclonal AntibodiesIBA 12/2001 - 09/2000
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2018
1	hydroxide ionIBA 01/2017
1	B7-H1 AntigenIBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	Biological ProductsIBA 05/2005
1	apolizumabIBA 12/2001
1	Paclitaxel (Taxol)FDA LinkGeneric 02/2001
1	CpG ODN 2006IBA 01/2001
1	OligodeoxyribonucleotidesIBA 01/2001
1	CPG-oligonucleotideIBA 01/2001
1	AntigensIBA 01/2001

Therapy/Procedure

5	Therapeutics 10/2008 - 09/2000
2	Drug Therapy (Chemotherapy) 11/2005 - 01/2001
2	Adjuvant Chemotherapy 09/2001 - 02/2001
1	Liver Transplantation 11/2004
1	Organ Transplantation 11/2004
1	Immunotherapy 01/2001